February 21, 2024 | 11:00 AM IST |
1:30 PM SGT | 4:30 PM AEDT
The Clarivate Drugs to Watch report spotlights recently-launched or soon-to-launch drugs with the potential to change treatment paradigms and/or reach blockbuster status within five years.
In this 2024 edition of Drugs to Watch, we highlight some of the trends that will be consequential to the discovery, development and delivery of new medicines, and spotlight drugs and drug candidates that will achieve important milestones in the coming years as they establish themselves as either blockbuster or breakthrough medicines.
Join our exclusive webinar as our panel deeps dives into each of the identified drugs and key trends.
Register below and we'll send the details straight to your inbox.
“Due to the ease of access and the variety of content and formats available, ExLibris will enable our academic community to access information that produces
better outcomes.”
Tomomi Asano, Manager of the Public Service Group at International
Christian
University Library
“Due to the ease of access and the variety of content and formats available, ExLibris will enable our academic community to access information that produces
better outcomes.”
Tomomi Asano, Manager of the Public Service Group at International
Christian
University Library
“Due to the ease of access and the variety of content and formats available, ExLibris will enable our academic community to access information that produces
better outcomes.”
Tomomi Asano, Manager of the Public Service Group at International
Christian
University Library
